SCT Files New Patent for the Cure of Type-1 Diabetes

Written By Travis Manning

Inventors Christof Westenfelder, Anna Gooch, Ping Zhang, and Zhuma Hu filed a new patent for "Neo-Islets Comprising Stem and Islet Cells and Treatment of Diabetes Mellitus Therewith". Dr. Westenfelder said, "Our cell cluster technology overcomes all major hurdles and limitations that exist in the field of cell-based therapies for Type-1 Diabetes Mellitus." 

Travis Manning https://www.symbiocelltech.com
Previous

World Health Organization Publishes Global Report on Diabetes and Calls For Action
Next

SymbioCellTech raises $2.5M seed funding